Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ONMD vs NVDA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ONMD
OneMedNet Corporation

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$32M
5Y Perf.-90.3%
NVDA
NVIDIA Corporation

Semiconductors

TechnologyNASDAQ • US
Market Cap$5.05T
5Y Perf.+938.3%

ONMD vs NVDA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ONMD logoONMD
NVDA logoNVDA
IndustryMedical - Healthcare Information ServicesSemiconductors
Market Cap$32M$5.05T
Revenue (TTM)$1M$215.94B
Net Income (TTM)$-3M$120.07B
Gross Margin-37.0%71.1%
Operating Margin-7.1%60.4%
Forward P/E25.1x
Total Debt$570K$11.41B
Cash & Equiv.$585K$10.61B

ONMD vs NVDALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ONMD
NVDA
StockJun 21May 26Return
OneMedNet Corporati… (ONMD)1009.7-90.3%
NVIDIA Corporation (NVDA)1001038.3+938.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: ONMD vs NVDA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ONMD and NVDA are tied at the top with 3 categories each — the right choice depends on your priorities. NVIDIA Corporation is the stronger pick specifically for profitability and margin quality and dividend income and shareholder returns. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ONMD
OneMedNet Corporation
The Income Pick

ONMD carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 0.37
  • Rev growth 111.4%, EPS growth 83.3%, 3Y rev CAGR 5.6%
  • Lower volatility, beta 0.37, current ratio 0.43x
Best for: income & stability and growth exposure
NVDA
NVIDIA Corporation
The Long-Run Compounder

NVDA is the clearest fit if your priority is long-term compounding.

  • 234.3% 10Y total return vs ONMD's -90.3%
  • 55.6% margin vs ONMD's -206.1%
  • 0.0% yield; 2-year raise streak; the other pay no meaningful dividend
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthONMD logoONMD111.4% revenue growth vs NVDA's 65.5%
Quality / MarginsNVDA logoNVDA55.6% margin vs ONMD's -206.1%
Stability / SafetyONMD logoONMDBeta 0.37 vs NVDA's 1.73
DividendsNVDA logoNVDA0.0% yield; 2-year raise streak; the other pay no meaningful dividend
Momentum (1Y)ONMD logoONMD+134.4% vs NVDA's +82.9%
Efficiency (ROA)NVDA logoNVDA58.1% ROA vs ONMD's -145.0%

ONMD vs NVDA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ONMDOneMedNet Corporation
FY 2025
Subscription Revenue
100.0%$105,000
NVDANVIDIA Corporation
FY 2026
Data Center
89.7%$193.7B
Gaming
7.4%$16.0B
Professional Visualization
1.5%$3.2B
Automotive
1.1%$2.3B
OEM And Other
0.3%$619M

ONMD vs NVDA — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLONMDLAGGINGNVDA

Income & Cash Flow (Last 12 Months)

NVDA leads this category, winning 5 of 6 comparable metrics.

NVDA is the larger business by revenue, generating $215.9B annually — 158894.8x ONMD's $1M. NVDA is the more profitable business, keeping 55.6% of every revenue dollar as net income compared to ONMD's -2.1%. On growth, ONMD holds the edge at +33.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricONMD logoONMDOneMedNet Corpora…NVDA logoNVDANVIDIA Corporation
RevenueTrailing 12 months$1M$215.9B
EBITDAEarnings before interest/tax-$10M$133.2B
Net IncomeAfter-tax profit-$3M$120.1B
Free Cash FlowCash after capex-$8M$96.7B
Gross MarginGross profit ÷ Revenue-37.0%+71.1%
Operating MarginEBIT ÷ Revenue-7.1%+60.4%
Net MarginNet income ÷ Revenue-2.1%+55.6%
FCF MarginFCF ÷ Revenue-5.5%+44.8%
Rev. Growth (YoY)Latest quarter vs prior year+33.2%+73.2%
EPS Growth (YoY)Latest quarter vs prior year+26.3%+97.8%
NVDA leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

ONMD leads this category, winning 2 of 2 comparable metrics.
MetricONMD logoONMDOneMedNet Corpora…NVDA logoNVDANVIDIA Corporation
Market CapShares × price$32M$5.05T
Enterprise ValueMkt cap + debt − cash$31M$5.05T
Trailing P/EPrice ÷ TTM EPS-16.02x42.38x
Forward P/EPrice ÷ next-FY EPS est.25.09x
PEG RatioP/E ÷ EPS growth rate0.44x
EV / EBITDAEnterprise value multiple37.89x
Price / SalesMarket cap ÷ Revenue23.18x23.37x
Price / BookPrice ÷ Book value/share32.26x
Price / FCFMarket cap ÷ FCF52.21x
ONMD leads this category, winning 2 of 2 comparable metrics.

Profitability & Efficiency

ONMD leads this category, winning 3 of 5 comparable metrics.

On the Piotroski fundamental quality scale (0–9), ONMD scores 5/9 vs NVDA's 4/9, reflecting solid financial health.

MetricONMD logoONMDOneMedNet Corpora…NVDA logoNVDANVIDIA Corporation
ROE (TTM)Return on equity+76.3%
ROA (TTM)Return on assets-145.0%+58.1%
ROICReturn on invested capital+81.8%
ROCEReturn on capital employed+97.2%
Piotroski ScoreFundamental quality 0–954
Debt / EquityFinancial leverage0.07x
Net DebtTotal debt minus cash-$15,000$807M
Cash & Equiv.Liquid assets$585,000$10.6B
Total DebtShort + long-term debt$570,000$11.4B
Interest CoverageEBIT ÷ Interest expense-40.79x545.03x
ONMD leads this category, winning 3 of 5 comparable metrics.

Total Returns (Dividends Reinvested)

NVDA leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in NVDA five years ago would be worth $143,108 today (with dividends reinvested), compared to $971 for ONMD. Over the past 12 months, ONMD leads with a +134.4% total return vs NVDA's +82.9%. The 3-year compound annual growth rate (CAGR) favors NVDA at 92.4% vs ONMD's -55.3% — a key indicator of consistent wealth creation.

MetricONMD logoONMDOneMedNet Corpora…NVDA logoNVDANVIDIA Corporation
YTD ReturnYear-to-date-21.2%+10.0%
1-Year ReturnPast 12 months+134.4%+82.9%
3-Year ReturnCumulative with dividends-91.1%+612.7%
5-Year ReturnCumulative with dividends-90.3%+1331.1%
10-Year ReturnCumulative with dividends-90.3%+23433.1%
CAGR (3Y)Annualised 3-year return-55.3%+92.4%
NVDA leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ONMD and NVDA each lead in 1 of 2 comparable metrics.

ONMD is the less volatile stock with a 0.37 beta — it tends to amplify market swings less than NVDA's 1.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVDA currently trades 95.8% from its 52-week high vs ONMD's 22.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricONMD logoONMDOneMedNet Corpora…NVDA logoNVDANVIDIA Corporation
Beta (5Y)Sensitivity to S&P 5000.37x1.73x
52-Week HighHighest price in past year$4.22$216.80
52-Week LowLowest price in past year$0.31$110.82
% of 52W HighCurrent price vs 52-week peak+22.8%+95.8%
RSI (14)Momentum oscillator 0–10053.350.8
Avg Volume (50D)Average daily shares traded5.2M166.2M
Evenly matched — ONMD and NVDA each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricONMD logoONMDOneMedNet Corpora…NVDA logoNVDANVIDIA Corporation
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$278.83
# AnalystsCovering analysts79
Dividend YieldAnnual dividend ÷ price+0.0%
Dividend StreakConsecutive years of raises2
Dividend / ShareAnnual DPS$0.04
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.8%
Insufficient data to determine a leader in this category.
Key Takeaway

NVDA leads in 2 of 6 categories (Income & Cash Flow, Total Returns). ONMD leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.

Best OverallOneMedNet Corporation (ONMD)Leads 2 of 6 categories
Loading custom metrics...

ONMD vs NVDA: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is ONMD or NVDA a better buy right now?

For growth investors, OneMedNet Corporation (ONMD) is the stronger pick with 111.

4% revenue growth year-over-year, versus 65. 5% for NVIDIA Corporation (NVDA). NVIDIA Corporation (NVDA) offers the better valuation at 42. 4x trailing P/E (25. 1x forward), making it the more compelling value choice. Analysts rate NVIDIA Corporation (NVDA) a "Buy" — based on 79 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — ONMD or NVDA?

Over the past 5 years, NVIDIA Corporation (NVDA) delivered a total return of +1331%, compared to -90.

3% for OneMedNet Corporation (ONMD). Over 10 years, the gap is even starker: NVDA returned +234. 3% versus ONMD's -90. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — ONMD or NVDA?

By beta (market sensitivity over 5 years), OneMedNet Corporation (ONMD) is the lower-risk stock at 0.

37β versus NVIDIA Corporation's 1. 73β — meaning NVDA is approximately 362% more volatile than ONMD relative to the S&P 500.

04

Which is growing faster — ONMD or NVDA?

By revenue growth (latest reported year), OneMedNet Corporation (ONMD) is pulling ahead at 111.

4% versus 65. 5% for NVIDIA Corporation (NVDA). On earnings-per-share growth, the picture is similar: OneMedNet Corporation grew EPS 83. 3% year-over-year, compared to 66. 7% for NVIDIA Corporation. Over a 3-year CAGR, NVDA leads at 100. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — ONMD or NVDA?

NVIDIA Corporation (NVDA) is the more profitable company, earning 55.

6% net margin versus -206. 1% for OneMedNet Corporation — meaning it keeps 55. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVDA leads at 60. 4% versus -711. 3% for ONMD. At the gross margin level — before operating expenses — NVDA leads at 71. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — ONMD or NVDA?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is ONMD or NVDA better for a retirement portfolio?

For long-horizon retirement investors, OneMedNet Corporation (ONMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

37)). NVIDIA Corporation (NVDA) carries a higher beta of 1. 73 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ONMD: -90. 3%, NVDA: +234. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between ONMD and NVDA?

These companies operate in different sectors (ONMD (Healthcare) and NVDA (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ONMD

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 1661%
Run This Screen
Stocks Like

NVDA

High-Growth Quality Leader

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 36%
  • Net Margin > 33%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ONMD and NVDA on the metrics below

Revenue Growth>
%
(ONMD: 3323.1% · NVDA: 73.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.